Form 8-K - Current report:
SEC Accession No. 0001564590-19-007016
Filing Date
2019-03-08
Accepted
2019-03-08 16:30:45
Documents
1
Period of Report
2019-03-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K agle-8k_20190308.htm 8-K 33730
  Complete submission text file 0001564590-19-007016.txt   34966
Mailing Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746
Business Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37722 | Film No.: 19669505
SIC: 2834 Pharmaceutical Preparations